Stocks股票 / Health Care / HSIC
HSIC US listed · USD美股 · 美元
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories.亨利·沙因公司是一家美国医疗保健产品和服务经销商,业务遍及33个国家和地区。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-04Estimates being raised — 1 analysts预期上调 — 1 位分析师
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | HSIC | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 23.82x | 28.59 | |
| P/B市净率 | 3.08x | 3.44 | |
| P/S市销率 | 0.76x | 2.97 | |
| Earnings yield盈利收益率 | 4.20% | 2.72 | |
| FCF yield自由现金流收益率 | 5.74% | 4.00 | |
| Shareholder yield股东收益率 | 8.52% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 10.19x | 18.18 | |
| P/FCF市值/自由现金流 | 17.42x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$8.6M net (0 buyers, 5 sellers)-$8.6M 净值(0 买家,5 卖家)
Signal history信号历史
engine events引擎事件Company profile公司档案
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories.亨利·沙因公司是一家美国医疗保健产品和服务经销商,业务遍及33个国家和地区。
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 23.8× | 28.6× | 63% |
| Price / Book市净率 | 3.1× | 3.4× | 55% |
| Price / Sales市销率 | 0.8× | 3.0× | 87% |
| EV / EBITDAEV/EBITDA | 10.2× | 18.2× | 89% |
| Earnings yield盈利收益率 | 4.2% | 2.7% | 73% |
| Free-cash-flow yield自由现金流收益率 | 7.1% | 5.5% | 70% |
| Shareholder yield股东综合回报率 | 8.5% | 1.9% | 94% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +0.5% | -0.9% |
| 1 Month近1月 | +7.9% | -0.6% |
| 3 Months近3月 | +9.3% | +5.4% |
| 6 Months近6月 | +9.2% | +8.6% |
| Year to date年初至今 | +12.2% | +8.9% |
| 1 Year近1年 | +24.7% | +19.2% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $10.1B | $12.4B | $12.6B | $12.3B | $12.7B | $13.2B |
| EPS每股收益 | $2.82 | $4.45 | $3.91 | $3.16 | $3.05 | $3.27 |
| Free cash flow自由现金流 | $550M | $631M | $506M | $353M | $700M | $573M |
| Gross margin毛利率 | 27.8% | 29.6% | 30.3% | 31.3% | 31.7% | 31.1% |
| Net margin净利率 | 4.0% | 5.1% | 4.3% | 3.4% | 3.1% | 3.0% |
| FCF margin自由现金流利润率 | 5.4% | 5.1% | 4.0% | 2.9% | 5.5% | 4.3% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量:应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: gross margin +3.3pts over 6 years定价能力:毛利率 6 年上升 3.3 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 2.84 — grey zone资产负债表:Altman Z 2.84——灰色区